Comparison
Bring HCP Analysis In-House
The Alternative to Outsourced HCP Testing
Comparison
The Alternative to Outsourced HCP Testing
Outsourcing host cell protein analysis means waiting weeks for someone else’s queue, paying per sample, and handing your most sensitive process data to a third party. The reason most teams outsource – that LC-MS HCP software was too complex to run routinely – no longer holds. This is the case for bringing HCP analysis in-house, and how SpotMap MS makes it practical.
Sending HCP work to a service provider made sense when LC-MS analysis required specialist software and a specialist to drive it. That constraint is gone. What’s left are the costs that never showed up on the invoice.
Your sample joins a backlog you don’t control. A failed run, a clarification email, a busy month at the provider — each adds a turnaround cycle. Decisions that should take days end up taking a quarter.
Outsourced HCP analysis is priced per sample. The more your programs succeed and the more batches you run, the faster the bill grows. In-house software flips that relationship: cost is fixed, throughput is yours.
Want to re-run with a different FASTA, re-examine a borderline spectrum, or check a specific high-risk HCP? In-house, that’s an afternoon. Outsourced, it’s a new request, a new quote and a new wait.
HCP profiles reveal a great deal about your cell line, your process and your product. Every outsourced campaign means handing that to a third party – and trusting their security, their data retention, and their staff turnover.
Every outsourced run is knowledge built outside your team. Bring it in-house and your analysts build durable LC-MS HCP capability – an asset that compounds across every future program.
The same HCP analysis, two operating models. Here is how they differ on the things that matter to an analytical development or QC lead.
| Consideration | Outsourced HCP service | SpotMap MS, in-house |
|---|---|---|
| Turnaround | Weeks, dictated by the provider's queue | Hours — run it when you need it, automated end-to-end |
| Cost model | Per sample — scales up with your success | Fixed per-seat license, unlimited samples |
| Re-analysis | A new request, quote and wait each time | Re-run with new parameters in an afternoon, no extra cost |
| Data & IP | Your process data sits on a third party's systems | Everything stays inside your building |
| Capability | Expertise stays outside your organization | Your analysts build durable LC-MS HCP expertise |
| Audit position | You depend on their compliance posture | 21 CFR Part 11 / Annex 11 via AuditSafe — under your control |
| Throughput ceiling | Limited by what you can afford to send out | As many batches as your instruments can acquire |
The reason you outsourced was that the software was too complex to run routinely. SpotMap MS was built to remove exactly that barrier. Here is the whole workflow.
Give SpotMap MS your FASTA file and your raw LC-MS trace files. Use your own proprietary library, a commercial one, or TotalLab’s pre-loaded CHO, E. coli and HEK libraries.
SpotMap MS performs the full HCP analysis end-to-end using DIA (data-independent acquisition) methodology. No method-building, no parameter wrangling. Set it and walk away.
The AI-powered HCP database scores identified proteins by published risk. Visual QC flags any failed technical replicates before they cost you time. You see what matters first.
Out comes a comprehensive HCP report. With AuditSafe, the whole thing is audit-trailed and e-signed — ready for a regulated QC environment, generated entirely in-house.
The three objections we hear most from teams who have outsourced HCP for years — and why each one is now a solved problem.
That was the whole problem SpotMap MS was built to solve. It needs an LC-MS instrument and your sample — not a dedicated informatics specialist. The free trial includes a guided walk-through with a TotalLab application scientist who has run HCP analysis on real biotherapeutic data.
Paired with AuditSafe, SpotMap MS gives you a fully audit-trailed, e-signed, GxP-ready environment — designed against 21 CFR Part 11, EudraLex Annex 11, GAMP and ALCOA+. An in-person IQ/OQ package is available for regulated installations.
You keep them. SpotMap MS sits alongside SpotMap ELISA and SpotMap 2D, so your orthogonal HCP coverage – LC-MS, ELISA and antibody coverage by 2D – all lives in-house, under one vendor, in one compliance framework.
“Typically with proteomics-based software to search against the CHO proteome, we don’t have much functionality to validate spectra. As a result, the output becomes ‘here is a list of proteins we identified and their relative abundance’ – if we wanted to validate those matches it could easily take twice as long without SpotMap MS.”
— Senior pharmaceutical analytical scientist
Bringing HCP analysis in-house should not mean taking on compliance risk. Paired with TotalLab’s AuditSafe wrapper, SpotMap MS gives you an audit-trailed, e-signed environment that stands up to inspection — the same wrapper already in production at major pharma companies. It is designed to meet:
– FDA 21 CFR Part 11
– USP <1132.1> (Residual Host Cell Protein Measurement in Biopharmaceuticals)
– EudraLex Annex 11
– ISPE GAMP and ALCOA+ data integrity principles
For regulated installations, TotalLab provides an in-person IQ/OQ package as part of the software validation pathway.
If you already have an LC-MS instrument acquiring suitable data, you can be running analyses during the free trial. SpotMap MS automates the analysis end-to-end – point it at a FASTA file and your raw MS files and it produces a comprehensive HCP report without active supervision. The guided onboarding session with a TotalLab application scientist gets your team productive immediately.
You gain your own instead. The expertise a provider builds stays with them; every in-house run builds durable capability inside your team. And you are not alone – TotalLab’s application scientists support you, and the pre-loaded, peer-reviewed HCP threat-scoring library encodes a great deal of HCP domain knowledge directly into the software.
Yes — and most teams should. ELISA and LC-MS are orthogonal and most regulated HCP programs need both. SpotMap MS pairs with PlateLogic and SpotMap 2D so your full orthogonal HCP toolkit lives in-house under one vendor and one compliance framework.
With AuditSafe, SpotMap MS operates in a fully audit-trailed, e-signed environment designed against 21 CFR Part 11, EudraLex Annex 11, GAMP and ALCOA+. TotalLab provides an in-person IQ/OQ package for regulated installations as part of the validation pathway. You move from depending on a provider’s compliance posture to controlling your own.
Outsourcing is priced per sample, so the cost grows with your throughput. SpotMap MS is a fixed per-seat license with unlimited samples – the more HCP analysis you do, the more the economics favor in-house. Book a demo and we will model the crossover point against your current outsourced volume.
SpotMap MS is vendor-neutral and works with raw MS files from the major instrument manufacturers via standard exchange formats, built around DIA (data-independent acquisition) methodology — the LC-MS HCP workflow across the industry.
Start a free trial and run your own HCP analysis this week — or book a 30-minute call to model the in-house vs outsourced economics against your current volume.